Management of ventricular arrhythmias in structural heart disease
Jason T Jacobson1, Sei Iwai, Wilbert Aronow
1Division of Cardiology, Department of Medicine, Westchester Medical Center, New York Medical College , Valhalla, New York , USA.
Insights
Ventricular arrhythmias (VA) in structural heart disease (SHD) patients cause significant problems. This review covers advanced treatments like catheter ablation and ICD programming for secondary prevention.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiac Arrhythmias
Background:
- Ventricular arrhythmias (VA) are a major cause of morbidity and mortality in patients with structural heart disease (SHD).
- While implantable cardiac defibrillators (ICDs) reduce mortality, associated morbidity remains a significant challenge.
- Current VA management extends beyond traditional anti-arrhythmic drugs.
Purpose of the Study:
- To review the spectrum of management strategies for ventricular arrhythmias in patients with structural heart disease.
- To focus on secondary prevention of VA in this patient population.
- To evaluate the clinical evidence supporting various treatment modalities.
Main Methods:
- Review of current literature and clinical evidence.
- Discussion of therapeutic strategies including medical therapy, ICD implantation and programming, catheter ablation, and autonomic modulation.
- Emphasis on secondary prevention approaches for VA in SHD.
Main Results:
- Modern VA treatment encompasses a range of interventions from device programming to complex procedures.
- Intelligent ICD programming and catheter ablation represent advanced therapeutic options.
- Autonomic modulation is also considered in the management of VA.
Conclusions:
- A comprehensive approach is necessary for managing VA in SHD patients.
- Advanced strategies like catheter ablation and optimized ICD programming are crucial for secondary prevention.
- Evidence-based utilization of these diverse treatments can improve patient outcomes.
Abstract:
Ventricular arrhythmias (VA) are a source of significant morbidity and mortality in patients with structural heart disease (SHD). The advent of the implantable cardiac defibrillator (ICD) has had a positive effect on mortality, but the associated morbidity remains a significant problem. Modern treatment of VA has advanced far beyond medical therapy and includes strategies as simple as intelligent ICD programming and as complex as catheter ablation (CA). In these pages, the spectrum of management strategies will be discussed; from anti-arrhythmic drugs and ICD implantation and programming to CA and autonomic modulation. The focus of this review will be on strategies for secondary prevention of VA in patients with SHD, supported by clinical evidence for their utilization.
More Related Videos
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
08:42Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dysrhythmias V: Evaluating Dysrhythmias
